26 results on '"Del Mastro L"'
Search Results
2. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
3. Lapatinib concentration in cerebrospinal fluid in two patients with HER2-positive metastatic breast cancer and brain metastases
4. Letrozole withdrawal response in locally advanced breast cancer
5. Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study
6. Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?
7. Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer
8. The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients
9. Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group
10. Taxane-containing chemotherapy in the treatment of early breast cancer patients
11. Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
12. Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
13. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients
14. Reply to “Weekly paclitaxel in elderly breast cancer patients”, by C. Smorenburg et al. (Ann Oncol 2005; 16: 1979)
15. Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
16. A multistep randomized phase II/III trial comparing oxaliplatin (OXA)+5 fluorouracil (FU) to vinorelbine (VIN)+FU (FUN) after taxane (T)/anthracycline (A) failure in advanced/metastatic breast cancer (MBC) patients (pts): Final results.: 660
17. PREVENTION OF CHEMOTHERAPY INDUCED EARLY MENOPAUSE BY TEMPORARY OVARIAN SUPPRESSION WITH GOSERELIN IN PREMENOPAUSAL BREAST CANCER PATIENTS. A PHASE II STUDY
18. Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients
19. Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study
20. Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
21. Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancer
22. Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
23. Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients
24. Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery*
25. MANTA1 STUDY: PACLITAXEL MAINTENANCE AFTER FIRST LINE CHEMOTHERAPY WITH ANTHRACYCLINES PLUS PACLITAXEL IN METASTATIC BREAST CANCER PATIENTS
26. A PHASE I DOSE-FINDING STUDY OF CAPECITABINE IN COMBINATION WITH EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER PATIENTS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.